Breast Cancer Research and Treatment

, Volume 121, Issue 1, pp 257–260 | Cite as

Broad BRCA1 and BRCA2 mutational spectrum and high incidence of recurrent and novel mutations in the eastern Spain population

  • Eva Esteban Cardeñosa
  • Pascual Bolufer Gilabert
  • Inmaculada de Juan Jimenez
  • Sarai Palanca Suela
  • Eva Barragán González
  • Isabel Chirivella González
  • Ángel Segura Huerta
  • Carmen Guillén Ponce
  • Eduardo Martínez de Dueñas
Letter to the Editor

To the Editor,

It is well known that the pathogenic mutations in BRCA1 or BRCA2 genes are detected in 5–10% of total breast (BC) and ovarian cancer (OC) and in 20–30% of BC/OC found in families with strong history of cancer [1]. However, the incidence of the BRCA1 and BRCA2 pathogenic mutations depends on the criteria adopted to select the families to be studied [2], and the mutation spectrum varies considerable due to the influence of the ethnic groups [3]. In addition, ethnicity could substantiate the appearance of founder mutations coming from an old ancestor such as the recurrent mutations detected among Ashkenazim [4, 5].

The Program of Genetic Counselling in Cancer of Valencia Community was launched in March 2005 and we reported the results of the first 147 nonrelated families included, describing the preliminary mutational spectrum [6] and novel mutations [7]. However, since then, the number of subjects studied for BRCA1 and BRCA2mutations has increased considerably having...


Genetic Counselling BRCA2 Mutation Deleterious Mutation Frameshift Mutation Pathogenic Mutation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



We express our gratitude to the “Fundación para la Investigación del Hospital Universitario La Fe” for granting two contracts for Inmaculada de Juan and Sarai Palanca (Bch Sc Specialist in Clinical Analysis), which made possible their participation in this study. We also express our gratitude to the support given by the Instituto de Salud Carlos III, grant PI060505, and the Generalitat Valenciana, grants AP-042/07 and EVES 100/2008.


  1. 1.
    Wooster R, Webwe BL (2003) Breast and ovarian cancer. N Engl J Med 23:2339–2347CrossRefGoogle Scholar
  2. 2.
    Malone KE, Daling JR, Thompson JD et al (1998) BRCA1 mutations and breast cancer in the general population: analyses in women before age 35 years and in women before age 45 years with first-degree family history. JAMA 279:922–929CrossRefPubMedGoogle Scholar
  3. 3.
    Szabo CI, King MC (1997) Population genetics of BRCA1 and BRCA2. Am J Hum Genet 60:1013–1020PubMedGoogle Scholar
  4. 4.
    Simard J, Tonin P, Durocher F et al (1994) Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families. Nat Genet 8:392–398CrossRefPubMedGoogle Scholar
  5. 5.
    Neuhausen SL, Mazoyer S, Friedman L et al (1996) Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study. Am J Hum Genet 58:271–280PubMedGoogle Scholar
  6. 6.
    Esteban E, Bolufer P, Palanca S et al (2008) Mutaciones de BRCA1 y BRCA2 en familias estudiadas en el Programa de Consejo Genético en el Cáncer de la Comunidad Valenciana. Med Clin (Barc) 130:121–126CrossRefGoogle Scholar
  7. 7.
    Esteban E, Bolufer P, Palanca S et al (2007) Twenty-three novel BRCA1 and BRCA2 sequence alterations in breast and/or ovarian cancer families of Eastern Spain. Breast Cancer Res Treat 112:69–73CrossRefGoogle Scholar
  8. 8.
    FESEO. Tercer Libro Blanco de la Oncología. Federación de Sociedades Españolas de Oncología (Biete Solá A, Palacios Eito A, Calvo Manuel FA eds) (2002) FESEO, MadridGoogle Scholar
  9. 9.
    Conselleria de Sanitat (2003) Programa de Consejo Genético en el Cáncer. Grupo de Cáncer Hereditario, Plan Oncológico, Comunidad Valenciana, ValenciaGoogle Scholar
  10. 10.
    Miki Y, Swensen J, Shattuck-Eidens D et al (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66–71CrossRefPubMedGoogle Scholar
  11. 11.
    The Breast Cancer Information Core Database (BIC) Accessed 17 Dec 2009
  12. 12.
    Ganguly A, Rock MJ, Prockop DJ (1993) Conformation-sensitive gel electrophoresis for rapid detection of single-base differences in double-stranded PCR products and DNA fragments: evidence for solvent-induced bends in DNA heteroduplexes. Proc Natl Acad Sci USA 90:10325–10329CrossRefPubMedGoogle Scholar
  13. 13.
    Diez O, Osorio A, Duran M et al (2003) Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects. Hum Mutat 22:301–312CrossRefPubMedGoogle Scholar
  14. 14.
    Beristain E, Martínez-Bouzas C, Guerra I et al (2007) Differences in the frequency and distribution of BRCA1 and BRCA2 mutations in breast/ovarian cancer cases from the Basque country with respect to the Spanish population: implications for genetic counselling. Breast Cancer Res Treat 106:255–262CrossRefPubMedGoogle Scholar
  15. 15.
    Infante M, Duran M, Esteban-Cardeñosa E et al (2006) High proportion of novel mutations of BRCA1 and BRCA2 in breast/ovarian cancer patients from Castilla-León (central Spain). J Hum Genet 51:611–617CrossRefPubMedGoogle Scholar
  16. 16.
    Berkeley Drosophila Genome Project: FruitFly, Accessed 17 Dec 2009
  17. 17.
    Miramar MD, Calvo MT, Rodriguez A et al (2008) Genetic analysis of BRCA1 and BRCA2 in breast/ovarian cancer families from Aragon (Spain): two novel truncating mutations and a large genomic deletion in BRCA1. Breast Cancer Res Treat 112:353–358CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC. 2009

Authors and Affiliations

  • Eva Esteban Cardeñosa
    • 1
  • Pascual Bolufer Gilabert
    • 1
  • Inmaculada de Juan Jimenez
    • 1
  • Sarai Palanca Suela
    • 1
  • Eva Barragán González
    • 1
  • Isabel Chirivella González
    • 2
  • Ángel Segura Huerta
    • 3
  • Carmen Guillén Ponce
    • 4
  • Eduardo Martínez de Dueñas
    • 5
  1. 1.Laboratorio de Biología Molecular, Servicio de Biopatología Clínica, Escuela de Enfermería 7ª PlantaHospital Universitario La FeValenciaSpain
  2. 2.Unit of Genetic Counseling in CancerHospital Clínico UniversitarioValenciaSpain
  3. 3.Unit of Genetic Counseling in CancerHospital Universitario La FeValenciaSpain
  4. 4.Unit of Genetic Counseling in CancerHospital General de ElcheAlicanteSpain
  5. 5.Unit of Genetic Counseling in CancerConsorcio Hospital ProvincialCastellónSpain

Personalised recommendations